battle of glp-1 delivery technologies Advances in receptor agonists systems for obesity and diabetes Design of chimeric GLP-1A using

The impact of glucagon-like peptide-1 receptor agonists (GLP-1Ra) on bone health remains unclear

10.1038/379069a0 86

This work was partially supported by National Natural Science Foundation of China 81872915 (M.-W.W.), 82073904 (M.-W.W.), 32071203 (L.H.Z), 81922071 (Y.Z.), 81773792 (D.Y.), 81973373 (D.Y.) and 21704064 (Q.T.Z.)

For the first time, it has been observed in the orthotopic pancreatic cancer model that an irinotecan-loaded silicon nanoparticle of 130 nm in size was efficiently transported to the tumor site [159]

Modified DPP-4 can not only mask the enzymatic hydrolysis site of DPP-4 but also bind closely with albumin to reduce renal excretion and prolong the half-life

Well meet you where youre at helping you navigate food choices, manage side effects, protect your health, and feel confident in your plan moving forward